OGI - OGI TLRY APHA among premarket losers

Avenue Therapeutics (ATXI) -16% after FDA continues to review NDA for IV Tramadol.Lucira Health (LHDX) -12%.OrganiGram (OGI) -12% on FQ2 results.Zomedica (ZOM) -11%.Brooklyn ImmunoTherapeutics (BTX) -10%.Fortress Biotech (FBIO) -9%.Pintec Technology (PT) -8%.Digital Ally (DGLY) -8% pared yesterday's gain after curfew declared in Minneapolis and St. Paul.MoSys (MOSY) -8%.Xtant Medical (XTNT) -8%.Village Farms International (VFF) -7%.Color Star Technology (CSCW) -6%.Asensus Surgical (ASXC) -7%.Tilray (TLRY) -6%.Property Solutions Acquisition (PSAC) -6%.FuelCell Energy (FCEL) -6%.Aphria (APHA) -6% on analyst downgrade following FQ3 results.Amesite (AMST) -6% on launch of a pilot program with the EWIE Group of Companies to develop and implement an eLearning and eTraining platform.Odonate Therapeutics (ODT) -6%.Weidai (WEI) -6%.Plug Power (PLUG) -6%.

For further details see:

OGI, TLRY, APHA among premarket losers